What You Should Know: - Can we build relationships with AI therapy bots as well as we can with other human beings? This research says yes. - A recent peer-reviewed study in Frontiers of Wysa, an advanced conversational AI for mental health, shows people develop an emotional bond with its chatbot in much the same way people bond with a human therapist. This ‘therapeutic alliance’ is crucial in helping people meet the goals of treatment, the study found. Peer-reviewed study reveals
Read More
Digital Therapeutics | Digital Health | Evidence-Based Therapeutics Interventions
At-Home Digital Health Innovations Transforming Diabetes Care
If you’re looking for a silver lining in the COVID-19 dark cloud still enshrouding the world, consider this: The pandemic has turbocharged widespread acceptance of at-home digital health solutions. Forced to function in a world of social distancing, healthcare providers and physicians have quickly discovered how easily telehealth visits, remote patient monitoring (RPM) and digital therapeutics can improve patient care. Many of these digital health innovations are designed to address
Read More
Powered by Biofourmis, Blessing Health System Partners Launches Home Hospital Services
What You Should Know: - Blessing Health System, an integrated rural health system selects Biofourmis, a virtual care and digital therapeutics provider to launch its own home hospital services. - As part of the selection, Biofourmis is supporting the health system with its turnkey, end-to-end, home hospital solution for participation in the Rural Home Hospital project. Delivering Acute-Level Hospital Care Inside Patients’ Homes This new program allows caregivers to
Read More
DarioHealth Forms $30M Strategic Agreement with Sanofi U.S.
What You Should Know: - DarioHealth Corp., a provider of global digital therapeutics (DTx), announced it has entered into a $30M multi-year, strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, $30 million-dollar agreement will help accelerate commercial adoption of Dario's full suite of digital therapeutics and drive the expansion of digital health solutions on the Dario platform. - As part of the strategic agreement, Dario and Sanofi will
Read More
Massachusetts General Hospital to Co-Develop VR Digital Therapeutic for Stem Cell Patients
What You Should Know: - Massachusetts General Hospital ("MGH") announced a research agreement with Rocket VR Health, an emerging digital therapeutics company developing clinically validated virtual reality therapies that enhance the quality of life of cancer patients, their families and their caregivers. - The research will study the effects of daily Virtual Reality Therapy's effect on patients during their entire hospital stay. Partnership Details The
Read More
Omada Health Raises $192M to Expand Digital Therapeutics for Chronic Disease
What You Should Know: - Omada Health, a chronic care integrated healthcare provider, today announced its $192M in Series E funding round led by Fidelity Management & Research Company with participation from aMoon, existing investors Perceptive Advisors, Wellington Management, Civilization Ventures, and others. - Omada Health will utilize the funding to accelerate hiring at all levels to meet growing customer demands, a technological roadmap for care and coaching personalization to
Read More
Medisafe Launches Digital Document Exchange to Speed Up Medication Approvals
What You Should Know: - Today, Medisafe, a leading digital therapeutics and patient engagement company launches its new Digital Document Exchange module to streamline the medication approval process. - The solution enables patients to upload and submit required documentation directly through the company's app — speeding complex medication approval processes from an average of 24 days to 10 minutes and allowing patients to begin treatment therapy sooner. Digital Document Exchange
Read More
Pear Therapeutics Acquires 2 Depression Assets to Optimize Depression Product Candidate
What You Should Know: - Pear Therapeutics, Inc. (Nasdaq: PEAR), announced it has acquired two new digital therapeutic assets that it intends to integrate into a potential prescription digital therapeutic (PDT) to treat patients across a continuum of depression subtypes and severities. - Additionally, Pear announced yesterday the expansion of its existing initiative with Crossroads. Through this expansion, Pear’s PDTs, reSET® and reSET-O®, have the potential to reach thousands of additional
Read More
Commercializing Digital Therapeutic Solutions: Key Lessons Learned to Watch
The pandemic has set ablaze the white-hot market for Digital Therapeutics (DTx), which “deliver medical interventions directly to patients using evidence-based, clinically evaluated software to treat, manage, and prevent a broad spectrum of diseases and disorders1.” In 2020, a digital research firm projected the global DTx market to hit nearly $9 billion by 2025; a year later, its 2025 DTx forecast had increased to $56 billion2. One of the few bright spots of 2020 was how quickly and
Read More
MindMaze Secures $125M to Accelerate Commercialization of Digital Neurotherapeutics Platform
What You Should Know: - MindMaze, a SaaS-based digital neurotherapeutics platform raises $125M led by AlbaCore Capital Group, one of Europe's leading specialist investors focusing on public and private corporate credit markets. MindMaze delivers seamless digital assessments and therapeutics over the full continuum of care in over twenty countries, with thousands of patients suffering from neurological conditions. - MindMaze will use the proceeds to accelerate commercialization of and
Read More
